MEDINCELL SA (MEDCL.PA) Stock Income Statement
Europe - EPA:MEDCL - FR0004065605 - Common Stock
21.08 EUR
-0.16 (-0.75%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.42M | 9.03M | 9.89M | 4.09M | 8.19M | |||
| Minority Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 1.15M | 2.27M | 3.43M | 1.50M | 1.45M | |||
| Gross Profit | 24.27M | 6.77M | 6.46M | 2.59M | 6.74M | |||
| Operating Expenses | 35.01M | 27.61M | 30.51M | 26.40M | 22.31M | |||
| Research and Development | 21.57M | 17.51M | 23.23M | 20.91M | 17.05M | |||
| Selling, General, and Administrative Expenses | 13.84M | 11.42M | 9.38M | 8.26M | 7.32M | |||
| Operating Income | -10.74M | -20.84M | -24.05M | -23.81M | -15.58M | |||
| Interest Income/Expense | -7.44M | -3.98M | -7.93M | -945.00K | -3.47M | |||
| Other Income/Expense | 0.00 | 9.00K | -36.00K | -47.00K | 56.00K | |||
| Non Recurring Items | -99.00K | -133.00K | 6.00K | N/A | N/A | |||
| Income Before Taxes | -18.28M | -24.95M | -32.01M | -24.81M | -18.99M | |||
| Income Tax | 160.00K | 88.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -18.44M | -25.04M | -32.01M | -24.81M | -18.99M | |||
| EBITDA | -8.75M | -19.13M | -22.39M | -22.30M | -14.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.62 | -0.88 | -1.27 | -1.00 | -0.86 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.46% | 74.92% | 65.28% | 63.23% | 82.27% | |||
| Profit Margin | -72.54% | -277.21% | -323.69% | -606.50% | -231.93% | |||
| Operating Profit Margin | -42.26% | -230.78% | -243.22% | -582.25% | -190.28% | |||
All data in EUR